(Q37964897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

The neuropathological profile of mild cognitive impairment (MCI): a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

mild cognitive impairment

1 reference

inferred from title

cognitive dysfunction

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sally Hunter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mario Siervo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Fiona E. Matthews

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Carol Brayne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

D Harris

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D J Llewellyn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

6 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1056-1076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/mp.2011.147

17 January 2020

exact match

0 references

cites work

Operationalization of mild cognitive impairment: a graphical approach.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Mild cognitive impairment represents early-stage Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Stereologic evidence for persistence of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Interhemispheric distribution of Alzheimer disease and vascular pathology in brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The neuropathology of probable Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Role of the neuropathology of Alzheimer disease in dementia in the oldest-old

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Visual association pathology in preclinical Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neuropathologic features of amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neuropathology of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Pathological correlates of dementia in a longitudinal, population-based sample of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Amyloid load in nondemented brains correlates with APOE e4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Very mild senile dementia of the Alzheimer type. I. Clinical assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Stereological analysis of neuropil threads in the hippocampal formation: relationships with Alzheimer's disease neuronal pathology and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Small vascular and Alzheimer disease-related pathologic determinants of dementia in the oldest-old

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Regional Distribution of Neurofibrillary Tangles and Senile Plaques in the Cerebral Cortex of Elderly Patients: A Quantitative Evaluation of a One-Year Autopsy Population from a Geriatric Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Mild amyloid pathology in the primary visual system of nonagenarians and centenarians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Clinical validity of A beta-protein deposition staging in brain aging and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Plaque complement activation and cognitive loss in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Knight's move thinking? Mild cognitive impairment in a chess player.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Tau protein abnormalities associated with the progression of alzheimer disease type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Education modifies the association of amyloid but not tangles with cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neuropathological background of twenty-seven centenarian brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cortical microinfarcts and demyelination significantly affect cognition in brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The clinical use of structural MRI in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Synaptic degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The cell division cycle and the pathophysiology of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cdk5, the multifunctional surveyor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The roles of cyclin-dependent kinase 5 in dendrite and synapse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Activity-dependent control of slow synaptic vesicle endocytosis by cyclin-dependent kinase 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cdk5 is essential for synaptic vesicle endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Recent advances in understanding the roles of Cdk5 in synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Activation of caspase-6 in aging and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Synaptotagmins in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Synaptic proteins, neuropathology and cognitive status in the oldest-old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Oxidatively modified RNA in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Oxidative inactivation of the proteasome in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Oxidative stress in the progression of Alzheimer disease in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Oxidative damage in mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Oxidative stress in Alzheimer disease: a possibility for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Role of oxidative stress in the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Ribosome dysfunction is an early event in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Interplay between oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Increased matrix metalloproteinase 9 activity in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cholinotrophic molecular substrates of mild cognitive impairment in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

SIRT1 deacetylase activity and the maintenance of protein homeostasis in response to stress: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Complement activation in very early Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Cell "self-eating" (autophagy) mechanism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Isolated executive impairment and associated frontal neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Clinicopathological studies of the dementias from an epidemiological viewpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Neurodegeneration in an Aβ-induced model of Alzheimer’s disease: the role of Cdk5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

From proteomics to biomarker discovery in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Neuropeptide abnormalities in patients with early Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.147

7 January 2021

Identifiers

DOI

10.1038/MP.2011.147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference